Accuray Incorporated (ARAY) recently reported the installation of the first CyberKnife VSI System at Creekside Cancer Care in Lafayette, Colorado. The CyberKnife VSI System is the latest addition to Accuray’s CyberKnife family of products.
The new system will enable the Creekside Cancer Care center to offer expanded cancer treatment options from radiosurgery to high-precision radiation therapy. The Creekside Cancer Care center will begin treating patients with the CyberKnife VSI System from June 2010.
The new CyberKnife VSI System is touted to have a unique combination of speed and accuracy. The time taken to deliver a radiosurgery plan may be lowered by up to 50% without compromising accuracy, claims Accuray. The new system has fastened the ability to track and correct for tumor motion, which is important for treating lung cancer. This allows a greater number of patients to be treated non-invasively.
Headquartered in Sunnyvale, California, Accuray designs, develops and sells the CyberKnife System, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The CyberKnife System is the first and only commercially available intelligent robotic radiosurgery system designed to treat solid tumors anywhere in the body. This is an alternative to traditional surgery.
Presently, we have a ‘Neutral’ recommendation on Accuray.
Read the full analyst report on “ARAY”
Zacks Investment Research